Revenue ReboundA sustained top-line recovery and 31% annual revenue increase in 2025 indicate improving market traction and demand for the company's medical products. Durable revenue growth supports scale, allows fixed-cost absorption, and creates a runway for margin and operating leverage if the trend persists over multiple quarters.
Improved Cash GenerationConversion to positive operating and free cash flow is a structural improvement, enabling internal funding of working capital and reinvestment without heavy external financing. Reliable cash generation improves resilience, supports strategic investments, and reduces reliance on capital markets over the coming quarters.
Low Leverage / Strong Balance SheetA conservatively financed balance sheet with mid-single-digit debt-to-equity gives the company structural resilience to industry cycles and investment needs. Low leverage reduces refinancing risk, preserves liquidity headroom for R&D, commercialization, or M&A, and supports long-term operational stability.